PALL-CCA: Retrospective analysis of palliative second-line chemotherapy in cholangiocarcinoma patients

PALL-CCA: Retrospective analysis of palliative second-line chemotherapy in cholangiocarcinoma patients - PALL-CCA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030374

Enrollment

200

Registered

2022-09-28

Start date

2022-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22 C24

Interventions

Group 1: In this monocentric retrospective study we analyze the data of cholangiocarcinoma patients from 06/2014 to 09/2022 to evaluate their overall survival in a real-world-cohort, and their overall

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients treated at UMG during 06/2014 to 09/2022

Exclusion criteria

Exclusion criteria: Age under 18 years

Design outcomes

Primary

Measure	Time frame
overall survival, overall survival under first-line and second-line therapy, retrospective analysis	—

Secondary

Measure	Time frame
overall survival under further treatment lines, surgery, and molecular profiles of tumors	—

Countries

Germany

Contacts

Public ContactJohanna Reinecke

UMG Goettingen

johanna.reinecke@med.uni-goettingen.de0551 390

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026